Default image for pages

« All Events

Registration can be accessed here!

There is a temporary traffic pattern due to ongoing construction at the Four Points Sheraton in Norwood. To view this traffic pattern, please click here!

More details coming soon.

 

PNQIN Spring 2025 Summit Goal:

To communicate PNQIN quality improvement project updates with statewide perinatal teams and partner organizations. PNQIN’s current initiatives are focused on eliminating racial and ethnic inequities in maternal and neonatal outcomes.

Quick Details

Date May 22nd 2025, 8:00 am - 4:30 pm
Location
In-Person
Four Points by Sheraton Norwood
Speaker Guidelines for Inclusive Content & Delivery https://pnqinma.org/wp-content/uploads/2026/06/V1_PNQIN-Speaker-Guidelines-for-Inclusive-Content-Delivery.pdf PNQIN Speaker Guidelines for Inclusive Content & DeliveryV1, March 2026 These guidelines support inclusive speaker recruitment, educational content, and representation that reflect the diversity of PNQIN’s membership. Our...
Communication
Association of Prenatal Fentanyl Exposure With Neonatal Opioid Withdrawal Syndrome Severity Abstract OBJECTIVE: Opioid use disorder (OUD) in pregnancy has increased substantially, with illicitfentanyl now the most common illicit opioid. Limited data exist on the impact of antenatalfentanyl exposure on...
Neonatal Abstinence Syndrome Opioid and Substance Use Disorders
There is no excerpt because this is a protected post.
Updated Guidance from ACOG: Zuranolone and Brexanolone for Treatment of Postpartum Depression Co-authored by our MA PMHC Bundle Lead, Dr. Tiffany Moore Simas, this Clinical Practice Update provides revised guidance on the use of both Zuranolone and Brexanolone for management of...